Pharmacists for Fair Reimbursement What your state's PBM laws actually mean for community pharmacies
State Tracker Updated June 15, 2026

Rhode Island: what the PBM reimbursement law requires

Rhode Island requires PBMs to maintain transparent, properly-sourced MAC lists and to give pharmacies a MAC appeal resolved within 15 days — but it has no NADAC or acquisition-cost reimbursement floor. A 2024 floor bill was not enacted.

Status Partially enacted
Law R.I. Gen. Laws § 27-20.1-15.1 (and §§ 27-18-33.2, 27-41-38.2)
Effective date In force
Reimbursement basis No reimbursement floor. PBMs must disclose the basis of MAC lists, update MAC pricing, ensure listed drugs are appropriately rated and available, and include a MAC appeal process in every PBM-pharmacy contract. A 2024 NADAC-floor bill (S 2395) died in committee.
Professional dispensing fee Not specified in statute
Appeal route Contractual MAC appeal investigated and resolved within 15 days; denials require a reason and an available NDC; upheld appeals require a list adjustment within one day

Rhode Island’s in-force PBM law is a MAC transparency-and-appeals regime, not a reimbursement floor. PBMs must disclose how MAC lists are built, keep them updated, ensure listed drugs are appropriately rated and available, and include a MAC appeal in every pharmacy contract — investigated and resolved within 15 days, with a list adjustment required if the appeal succeeds.

A 2024 bill that would have set a NADAC-based reimbursement floor (S 2395) was left out of the Senate’s health-care package and did not become law. Its floor language can be mistaken for in-force law; it is not.

Sources

Back to the tracker